NOTE: This is a two-part webinar to be held on December 9, 2020 from 1PM – 2:30PM Central Time and on December 16, 2020 from 1PM – 2:30PM Central Time. 

Title:  Medication Updates 2020 Part 1 & 2

Session Description (Part 1): This session reviews the process of getting a drug to market by a pharmaceutical company and the requirements imposed by the FDA for such. It continues with several disease states and the medications developed in the last year to address some of the ongoing needs of patients, especially individuals with I/DD. The disease states and new drugs discussed are Parkinson’s Disease, Alzheimer’s Disease and Depression.

Session Description (Part 2):  This session continues with a discussion of disease states affecting the individual with I/DD and new drugs developed over the past year. The following topics are reviewed: Insomnia, Schizophrenia, Hypertension and Seizure Disorder. Lastly what is on the horizon for development is reviewed.

Speaker Bio:  Nanette is a pharmacist educator who has done training, education and speaking for physicians, nurses and other health professionals for many years. She focuses on clinical health and medication education in the area of intellectual and developmental disabilities.

Medication management, drug safety, treatment assessments, new drugs on the market and disease states are some of the many topics she has discussed for organizations all over the country. She has produced a national newsletter reaching thousands of health professionals and is widely sought after to present health education webinars on a variety of subjects impacting those individuals with intellectual and developmental disabilities.
 
She is one of the clinical resources for a national pharmacy, Tarrytown Expocare,specializing in providing medications and medication management to facilities across the United States who care for individuals with I/DD. She is skilled at facilitating health promotion and disease prevention by utilizing public talks and training seminars to increase understanding of medication usage, dosing, potential side effects and drug interactions in this disease state for nursing, physician and health care workers.  Nanette has spoken for drug companies for the past 16 years as a professional
medication educational speaker on a variety of subjects including seizure disorder, psychotropic medications, Alzheimer’s Disease, respiratory illnesses and osteoporosis as a few examples.
 
She has been nationally recognized by a number of organizations including the National Developmental Disabilities Nursing Association and the American Association of Intellectual and Developmental Disabilities by winning awards for her speaking commitments.

Cost:

Member: $30.00

Non-Member: $25.00

CEUs:  We are pleased to inform you that 1.5 continuing education hour(s) (CEs) are approved for the following licensed professionals: • Licensed Clinical Professional Counselor • Licensed Clinical Social Worker • Licensed Nursing Home Administrator • Licensed Professional Counselor • Licensed Social Worker • Registered Nurse, Licensed Practical Nurse & Advanced Practice Nurse Qualified Intellectual Disabilities Professionals.  QIDPs may apply the same hours of continuing education units earned from this conference toward their twelve hour annual continuing education requirement.

Funding provided in whole or in part by The Autism Program of Illinois and the Illinois Department of Human Services

The TEC Lab is proud to partner with NAQ.